Tubulin detyrosination, which results from the suppression of tubulin tyrosine ligase and the resulting unbalanced activity of tubulin-carboxypeptidase, apparently represents a strong selective advantage for cancer cells and has been linked to poor prognosis in BC [42]. Here, TTL is linked to breast cancer.